BETHLEHEM, Pa., Aug. 16, 2017 -- Attendees of the United Ostomy Associations of America (UOAA) conference will have the chance to learn about B. Braun Medical Inc.’s full line of ostomy products and a new program designed to provide support for ostomates and their caregivers.
The conference, in Irvine, California, takes place August 22-24, 2017. At booth #212, B. Braun will showcase the full line of the Flexima 3S® ostomy products, including:
- A high-performance filter and a guiding system designed for security
- Roll’Up Drainable Pouches with an integrated soft roll-up outlet
- B. Braun High Output System, including the High Output Pouch and Flow Collector with a 2-liter collection bag and 5-foot-long white tubing
- Urostomy Pouches with an open/closed tap with tactile feel drain
In addition to exhibiting its Flexima® products at the conference, B. Braun will preview its myostoSM education and support program for those living with or supporting someone with an ostomy.
“The myosto program will offer support and education for new ostomates and caregivers, as they learn to embrace a new beginning or continue to adjust to living with an ostomy,” said Jeff Straton, Director of New Business Development at B. Braun Medical. “We look forward to learning from the attendees at UOAA to help evolve our plans for myosto.”
For patients from pre-surgery to many years post-ostomy, the soon-to-be-launched myosto program also will offer information, support, and resources. The program will include a website, toll-free contact numbers, and an Ambassador Program.
For more information, visit www.BBraunUSA.com.
About B. Braun
B. Braun Medical Inc., a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry. The company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. B. Braun Medical is headquartered in Bethlehem, Pa., and is part of the B. Braun Group of Companies in the U.S., which includes B. Braun Interventional Systems, Aesculap® and CAPS®.
Globally, the B. Braun Group of Companies employs more than 58,000 employees in 64 countries. Guided by its Sharing Expertise® philosophy, B. Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs. To learn more about B. Braun Medical, visit www.BBraunUSA.com.
Contact: Jason Ford B. Braun Medical Inc. 610.997.4722 [email protected]


NRW Holdings Shares Surge After Securing Major Rio Tinto Contract and New Project Wins
Qantas to Sell Jetstar Japan Stake as It Refocuses on Core Australian Operations
CSPC Pharma and AstraZeneca Forge Multibillion-Dollar Partnership to Develop Long-Acting Peptide Drugs
Nvidia Confirms Major OpenAI Investment Amid AI Funding Race
Federal Judge Signals Possible Dismissal of xAI Lawsuit Against OpenAI
SoftBank and Intel Partner to Develop Next-Generation Memory Chips for AI Data Centers
Hyundai Motor Lets Russia Plant Buyback Option Expire Amid Ongoing Ukraine War
Denso Cuts Profit Forecast Amid U.S. Tariffs and Rising Costs
Panama Supreme Court Voids Hong Kong Firm’s Panama Canal Port Contracts Over Constitutional Violations
Using the Economic Calendar to Reduce Surprise Driven Losses in Forex
US Judge Rejects $2.36B Penalty Bid Against Google in Privacy Data Case
Panama Supreme Court Voids CK Hutchison Port Concessions, Raising Geopolitical and Trade Concerns
Nvidia’s $100 Billion OpenAI Investment Faces Internal Doubts, Report Says
Saks Global to End Saks on Amazon Partnership Amid Bankruptcy Restructuring
Jensen Huang Urges Taiwan Suppliers to Boost AI Chip Production Amid Surging Demand
Elon Musk’s Empire: SpaceX, Tesla, and xAI Merger Talks Spark Investor Debate
Sam Altman Reaffirms OpenAI’s Long-Term Commitment to NVIDIA Amid Chip Report 



